Company profile
Optibrium: Elegant Drug Discovery Tools & Technologies
Optibrium is at the forefront of developing innovative products that enhance the efficiency and productivity of drug discovery. Discover more!
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
AA | Transaction MzUyNTM4OTY5N2FkaXF6a2N4 | Paper/PDF filed
Published 08 Jun 2026 23:05
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzODQxMTM5NmFkaXF6a2N4
Published 04 Oct 2024 09:41
AA | Transaction MzQzNjUwMDgwN2FkaXF6a2N4 | Paper/PDF filed
Published 24 Sep 2024 06:37
Company registered at Companies House
1 Sep 2018 to 31 Aug 2020
Integrated through Optibrium's existing software offering (StarDrop(tm)), DeepADMET is a next-generation project that will develop and apply novel deep learning methods to extend and improve predictive models of important Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) endpoints to guide more efficient design and selection of high qua...
